Description

Myteka contains montelukast sodium. it is a selective leukotriene receptor antagonist that inhibits the effects of cysteinyl leukotrienes in the airways. It is used for the prophylaxis and chronic treatment of asthma in adults and pediatric patients aged 12 months and older. Additionally, it provides relief from symptoms of seasonal allergic rhinitis in adults and pediatric patients aged 2 years and older?